Notably, another independent study involving a pan-cancer analysis using multi-omics approach reveals that genetic as well as transcriptional aberrations in AMPK signaling elicits tissue-dependent pro- or anti-tumor impacts across major cancer types (126). Here, PRKAA2 is linked to cancer.